Когавант

Когавант (ticagrelor) is an oral antiplatelet medication used to reduce blood clot risk in cardiovascular conditions. This EU-manufactured generic supports heart health by preventing platelet aggregation. Ideal for those managing coronary artery disease or post-stent care. Short-term use under medical supervision is typical.

Ticagrelor is primarily used to prevent blood clots in people with coronary artery disease, including those who have had a heart attack or received a stent. It works by reducing platelet aggregation, which helps maintain healthy blood flow. Doctors may prescribe it alongside aspirin for dual antiplatelet therapy. This medication is not a cure but supports long-term cardiovascular health.

Common effects of ticagrelor include mild bleeding, such as nosebleeds or easy bruising, which are usually harmless. Some users report shortness of breath or dizziness, especially when starting treatment. These effects often lessen as the body adjusts. Always monitor your body’s response and report persistent issues to a healthcare provider.

Store ticagrelor at room temperature away from moisture and heat. Keep it in its original packaging to protect from light. Avoid crushing or splitting tablets unless advised by a doctor. If you miss a dose, take it as soon as you remember, but skip it if it’s nearly time for the next dose. Do not double up to compensate.

Ticagrelor may interact with other blood thinners, NSAIDs, or certain antidepressants, increasing bleeding risk. Grapefruit and its juice can affect how the drug works, so avoid them. Always inform your doctor about all medications, supplements, or herbal products you’re using. Alcohol should be consumed cautiously due to potential dizziness or bleeding risks.